BoltzMol-1
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- Boltz raises $110M Series A for AI drug discovery
London-based Boltz raised a $110 million Series A led by Bessemer Venture Partners, following a $28 million seed round in 2025. The company sells BoltzMol-1 and BoltzProt-1 through Boltz Lab and an API, offering molecular screening and protein design without operating its own drug pipeline. Boltz reported 50-fold growth in customer token consumption since June and said six of the 20 largest pharmaceutical companies were clients, though the supplied reports do not independently verify these usage and adoption figures.
SiliconANGLE AI · 🔥 9
Experience and discussion from the community
Share my BoltzMol-1 experienceAsk about BoltzMol-1
Nobody has shared their experience with BoltzMol-1 yet.